Gleevec inhibits β-amyloid production but not Notch cleavage

作者: W. J. Netzer , F. Dou , D. Cai , D. Veach , S. Jean

DOI: 10.1073/PNAS.1534745100

关键词:

摘要: Amyloid-β (Aβ) peptides, consisting mainly of 40 and 42 aa (Aβ40 Aβ42, respectively), are metabolites the amyloid precursor protein believed to be major pathological determinants Alzheimer's disease. The proteolytic cleavages that form Aβ N C termini catalyzed by β-secretase γ-secretase, respectively. Here we demonstrate γ-secretase generation in an N2a cell-free system is ATP dependent. In addition, Abl kinase inhibitor imatinib mesylate (Gleevec, or STI571), which targets ATP-binding site several other tyrosine kinases, potently reduces production intact cells. Both STI571 a related compound, 2, also reduce rat primary neuronal cultures vivo guinea pig brain. does not inhibit γ-secretase-catalyzed S3 cleavage Notch-1. Furthermore, its inhibition were demonstrated occur similar extents both Abl-/- WT mouse fibroblasts, indicating effect on involve kinase. efficacy reducing without affecting Notch-1 may prove useful as basis for developing novel therapies

参考文章(44)
John Kuriyan, John Kuriyan, Bayard Clarkson, David Wisniewski, Bhushan Nagar, Bhushan Nagar, William G. Bornmann, Darren R. Veach, Chongyuan Liu, Thomas Schindler, Thomas Schindler, Caryl L. Lambek, Matthew A. Young, Matthew A. Young, Annabel Strife, Joseph R. Bertino, Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases. Cancer Research. ,vol. 62, pp. 4244- 4255 ,(2002)
Mary Srethapakdi, Mark M. Moasser, Neal Rosen, Komal S. Sachar, Alan J. Kraker, Inhibition of Src Kinases by a Selective Tyrosine Kinase Inhibitor Causes Mitotic Arrest Cancer Research. ,vol. 59, pp. 6145- 6152 ,(1999)
D N Hebert, A Carruthers, Direct evidence for ATP modulation of sugar transport in human erythrocyte ghosts. Journal of Biological Chemistry. ,vol. 261, pp. 10093- 10099 ,(1986) , 10.1016/S0021-9258(18)67495-2
Christopher J. Phiel, Christina A. Wilson, Virginia M.-Y. Lee, Peter S. Klein, GSK-3α regulates production of Alzheimer's disease amyloid-β peptides Nature. ,vol. 423, pp. 435- 439 ,(2003) , 10.1038/NATURE01640
Eric H. Schroeter, Jeffrey A. Kisslinger, Raphael Kopan, Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. ,vol. 393, pp. 382- 386 ,(1998) , 10.1038/30756
Weiming Xia, Jimin Zhang, Beth L. Ostaszewski, William Taylor Kimberly, Peter Seubert, Edward H. Koo, Jie Shen, Dennis J. Selkoe, Presenilin 1 regulates the processing of β-amyloid precursor protein C- terminal fragments and the generation of amyloid β-protein in endoplasmic reticulum and Golgi Biochemistry. ,vol. 37, pp. 16465- 16471 ,(1998) , 10.1021/BI9816195
Huakui Yu, Carlos A. Saura, Se-Young Choi, Linus D. Sun, Xudong Yang, Melissa Handler, Takeshi Kawarabayashi, Linda Younkin, Bogdan Fedeles, Matthew A. Wilson, Steve Younkin, Eric R. Kandel, Alfredo Kirkwood, Jie Shen, APP Processing and Synaptic Plasticity in Presenilin-1 Conditional Knockout Mice Neuron. ,vol. 31, pp. 713- 726 ,(2001) , 10.1016/S0896-6273(01)00417-2
J. P. Greenfield, J. Tsai, G. K. Gouras, B. Hai, G. Thinakaran, F. Checler, S. S. Sisodia, P. Greengard, H. Xu, Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer β-amyloid peptides Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 742- 747 ,(1999) , 10.1073/PNAS.96.2.742